PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33976385-6	2021	Protection was lost in Il17A-/- mice and this was associated with significantly less infiltration of Siglec-F+ neutrophils and antimicrobial peptide (AMP) production.	Adenosine Monophosphate	150-153	interleukin 17A	Mus musculus	23-28	
25370709-11	2015	ZOL&DEX treatment suppressed the levels of RANKL and IL-17, but induced an upregulation of osteoprotegerin and FAM20C in both bones.	Adenosine Monophosphate	4-7	interleukin 17A	Mus musculus	57-62	
30307739-14	2018	NEW & NOTEWORTHY IL-23 is expressed early during cold ischemia-reperfusion (I/R), and this expression is associated with expression of IL-17 and chemokine (C-X-C motif) ligand 2.	Adenosine Monophosphate	5-8	interleukin 17A	Mus musculus	139-181	
28458392-8	2017	Collectively, these findings indicate that decreased miR-497 expression is responsible for IL-17-triggered high HIF-1alpha expression and consequent IL-1beta and IL-6 production by astrocytes in EAE mice.Cellular & Molecular Immunology advance online publication, 1 May 2017; doi:10.1038/cmi.2017.12.	Adenosine Monophosphate	214-217	interleukin 17A	Mus musculus	91-96	
26809113-1	2016	BACKGROUND & AIMS: The IL-23/IL-17 axis plays an important role in the pathogenesis of autoimmune diseases and the pathological consequences of infection.	Adenosine Monophosphate	12-15	interleukin 17A	Mus musculus	33-38	
23202375-6	2012	Further analysis showed that monocytes pretreated with IL-17 have reduced in vitro chemotaxis towards the ligand for CCR2, i.e., MCP-1/CCL2, and the ligand for CXCR4, i.e., SDF-1α/CXCL12.	Adenosine Monophosphate	179-182	interleukin 17A	Mus musculus	55-60